Viromed Medical AG / DE000A3MQR65

Viromed Medical AG seeks extensive cooperation with a major global Group

EQS-Ad-hoc: Viromed Medical AG / Key word(s): Alliance


11-Dec-2024 / 21:45 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Pinneberg, 11 December 2024 - Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; ‘Viromed’; the ‘Company’) is seeking an extensive cooperation with a major global Group that is also active in the pharmaceutical sector. Based on today's discussions, the subject of the cooperation will be in particular the granting of a worldwide licence in favour of Viromed Medical AG for the application of cold atmospheric pressure plasma in medicine. Subject to a contractual agreement, which is expected within the next three months, Viromed expects to generate initial revenues from the use of cold atmospheric pressure plasma in the low double-digit million range as early as the second half of the 2025 financial year. Another subject of the negotiations for the establishment of an extensive cooperation is a possible participation of the global Group in Viromed or, conversely, a participation of Viromed in portfolio companies of the global Group. However, decisive negotiations on the essential terms of the respective participations are still pending. Viromed will inform the capital market about the further progress of the negotiations on the intended cooperation in accordance with its legal obligation.   Contact Viromed Medical AG

Uwe Perbandt
CEO
Flensburger Straße 18
25421 Pinneberg
E-Mail: [e-mail]
www.viromed-medical-ag.de  

End of Inside Information

---

11-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---

Language:	English
Company:	Viromed Medical AG
	Flensburger Straße 18
	25421 Pinneberg
	Germany
Phone:	[phone]
E-mail:	[e-mail]
Internet:	https://www.viromed-medical-ag.de/
ISIN:	DE000A3MQR65
WKN:	A3MQR6
Listed:	Regulated Unofficial Market in Berlin, Dusseldorf (Primärmarkt), Frankfurt (Basic Board), Hamburg
EQS News ID:	2049425

End of Announcement	EQS News Service

---

2049425  11-Dec-2024 CET/CEST